Answers are grounded in this paper and cite their sources.
Barley and wheat are conventional sources of amylases for industrial applications; however, their cost and seasonal availability limit their utilisation. Underutilised grains, such as acha and iburu, may provide alternative sources of these enzymes. This study investigated the potential of malted acha and iburu as sources of amylases and optimised cross-linked enzyme aggregate (CLEA) technology for their immobilisation. Purified amylases obtained from the malted grains were precipitated using 80% (NH4)2SO4 for 30 min on ice, followed by cross-linking with glutaraldehyde at a final concentration of 2%. The concentrations of (NH4)2SO4 and glutaraldehyde were optimised on the basis of enzyme activity recovery. CLEAs were prepared using 80% (NH4)2SO4. The reusability of the amylase CLEAs from these grains was investigated over four cycles. The prepared CLEAs exhibited substantial residual activity after repeated use. After four successive cycles, 72% and 62% of the initial activities were retained by the acha and iburu amylase CLEAs, respectively. These findings suggest that malted acha and iburu are promising alternative sources of amylases, although further studies on scale-up, industrial applications, direct comparisons with commercial preparations and techno-economic feasibility are required.
No takes yet. Share an insight, caveat, or question.
Adefila et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: